Agilon Health Statistics
Want to see AGL full AI Analyst Report?
Agilon Health (AGL) Stock Statistics & Valuation Metrics
Total Valuation
Agilon Health has a market cap or net worth of $1.94B. The enterprise value is $1.13B.
- Market Cap
- $1.94B
- Enterprise Value
- $1.13B
Share Statistics
Agilon Health has 16,795,774 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 16,795,774
- Owned by Insiders
- 5.63%
- Owned by Institutions
- 74.61%
Financial Efficiency
Agilon Health’s return on equity (ROE) is -3.20 and return on invested capital (ROIC) is -196.72%.
- Return on Equity (ROE)
- -3.20
- Return on Assets (ROA)
- -0.32
- Return on Invested Capital (ROIC)
- -196.72%
- Return on Capital Employed (ROCE)
- -2.16
- Revenue Per Employee
- 6.93M
- Profits Per Employee
- -473.54K
- Employee Count
- 856
- Asset Turnover
- 4.67
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Agilon Health is -17.66. Agilon Health’s PEG ratio is -0.30.
- PE Ratio
- -17.66
- PS Ratio
- 0.32
- PB Ratio
- 6.92
- Price to FCF
- -62.51
- Price to Operating Cash Flow
- -458.73
- PEG Ratio
- -0.30
Income Statement
In the last 12 months, Agilon Health had revenue of 5.93B and earned -405.35M in profits. Earnings per share was -24.50.
- Revenue
- 5.93B
- Gross Profit
- -188.61M
- Operating Income
- -421.08M
- Pretax Income
- -404.10M
- Net Income
- -405.35M
- EBITDA
- -368.86M
- Earnings Per Share (EPS)
- -24.50
Cash Flow
In the last 12 months, operating cash flow was -4.23M and capital expenditures -26.84M, giving a free cash flow of -31.07M billion.
- Operating Cash Flow
- -4.23M
- Free Cash Flow
- -31.07M
- Free Cash Flow per Share
- -1.85
Dividends & Yields
Agilon Health pays an annual dividend of $0.45, resulting in a dividend yield of ―
- Dividend Per Share
- $0.45
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.60%
- Earnings Yield
- -5.46%
Stock Price Statistics
- Beta
- 2.86
- 52-Week Price Change
- 667.99%
- 50-Day Moving Average
- 90.83
- 200-Day Moving Average
- 69.84
- Relative Strength Index (RSI)
- 72.17
- Average Volume (3m)
- 216.84K
Important Dates
Agilon Health upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- Nov 16, 2011
Financial Position
Agilon Health as a current ratio of 1.02, with Debt / Equity ratio of 29.05%
- Current Ratio
- 1.02
- Quick Ratio
- 1.02
- Debt to Market Cap
- 0.12
- Net Debt to EBITDA
- 0.37
- Interest Coverage Ratio
- -63.41
Taxes
In the past 12 months, Agilon Health has paid 1.25M in taxes.
- Income Tax
- 1.25M
- Effective Tax Rate
- -0.00
Enterprise Valuation
Agilon Health EV to EBITDA ratio is -21.11, with an EV/FCF ratio of -57.98.
- EV to Sales
- 0.30
- EV to EBITDA
- -21.11
- EV to Free Cash Flow
- -57.98
- EV to Operating Cash Flow
- -425.51
Balance Sheet
Agilon Health has $239.76M in cash and marketable securities with $33.42M in debt, giving a net cash position of $206.34M billion.
- Cash & Marketable Securities
- $239.76M
- Total Debt
- $33.42M
- Net Cash
- $206.34M
- Net Cash Per Share
- $12.28
- Tangible Book Value Per Share
- $13.34
Margins
Gross margin is 2.76%, with operating margin of -1.83%, and net profit margin of -1.77%.
- Gross Margin
- 2.76%
- Operating Margin
- -1.83%
- Pretax Margin
- -1.68%
- Net Profit Margin
- -1.77%
- EBITDA Margin
- -1.42%
- EBIT Margin
- -1.88%
Analyst Forecast
The average price target for Agilon Health is $117.67, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- $117.67
- Price Target Upside
- 1.73% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 7
- Revenue Growth Forecast
- 2.02%
- EPS Growth Forecast
- 66.99%
Scores
- Smart Score
- 9
- AI Score
- 56

